Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of Ilaprazole 20 mg in patients with non-erosive reflux disease. This study intends to demonstrate the clinical superiority of Ilaprazole 20 mg to placebo administered once daily for 4 weeks.


Clinical Trial Description

This study is multicenter, randomized, parallel, double blind, placebo-controlled phase III study ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03444883
Study type Interventional
Source Il-Yang Pharm. Co., Ltd.
Contact
Status Completed
Phase Phase 3
Start date October 31, 2018
Completion date February 25, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05587322 - A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease Phase 3
Completed NCT02556021 - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease Phase 3
Completed NCT03591653 - A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks Phase 3
Completed NCT00562094 - Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) N/A
Completed NCT00259077 - Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population Phase 3
Enrolling by invitation NCT02149914 - The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients N/A
Terminated NCT00449813 - The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) Phase 4
Completed NCT02081404 - Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study N/A
Completed NCT01797939 - Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients N/A
Recruiting NCT04255693 - Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence N/A
Recruiting NCT04252144 - Study of Dietary Patterns and Food Diversity in Russian GERD Patients N/A
Recruiting NCT02892357 - Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease Phase 1/Phase 2
Completed NCT01750437 - Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) Phase 2
Completed NCT01560910 - Detection of Minimal Change Esophagitis by I-scan N/A
Completed NCT00830115 - Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders N/A
Completed NCT00259051 - A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population Phase 3
Not yet recruiting NCT04759378 - Comorbid Esophageal Disorders in IBS Patients N/A
Recruiting NCT05369884 - Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D Early Phase 1
Recruiting NCT06121830 - Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) Phase 3
Terminated NCT02788591 - Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection N/A